Snowden Capital Advisors LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 86 filers reported holding ENZO BIOCHEM INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Snowden Capital Advisors LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$30,099
-27.9%
21,499
-5.3%
0.00%0.0%
Q2 2023$41,766
-23.6%
22,699
+0.9%
0.00%
-50.0%
Q1 2023$54,673
+31.4%
22,499
-22.7%
0.00%0.0%
Q4 2022$41,619
-40.5%
29,104
-8.2%
0.00%
-33.3%
Q3 2022$70,000
+2.9%
31,704
-4.1%
0.00%0.0%
Q2 2022$68,000
-34.6%
33,054
-8.3%
0.00%
-25.0%
Q1 2022$104,000
+9.5%
36,054
+21.6%
0.00%
-20.0%
Q4 2021$95,000
-4.7%
29,649
-5.7%
0.01%0.0%
Q2 2021$99,693
-9.0%
31,449
-1.3%
0.01%
-16.7%
Q1 2021$109,561
+40.3%
31,849
+2.7%
0.01%
+20.0%
Q4 2020$78,117
+25.9%
30,999
+5.4%
0.01%0.0%
Q3 2020$62,032
-0.4%
29,399
+5.8%
0.01%0.0%
Q2 2020$62,270
+5.0%
27,799
+18.5%
0.01%
-16.7%
Q1 2020$59,329
+14.8%
23,450
-98.8%
0.01%
+50.0%
Q4 2019$51,680
-28.4%
1,965,000
-2.0%
0.00%
-42.9%
Q3 2019$72,212
+61.2%
2,005,900
+12124.4%
0.01%
+40.0%
Q1 2019$44,797
+16.7%
16,409
+18.8%
0.01%0.0%
Q4 2018$38,389
-7.8%
13,809
+36.6%
0.01%0.0%
Q3 2018$41,64910,1090.01%
Other shareholders
ENZO BIOCHEM INC shareholders Q1 2019
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,886,771$10,219,00013.54%
HARBERT FUND ADVISORS, INC. 5,175,913$18,323,0006.51%
Evermore Global Advisors, LLC 1,730,607$6,126,0005.39%
VIEX Capital Advisors, LLC 1,510,401$5,347,0003.24%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$90,0000.05%
RBF Capital, LLC 250,359$886,0000.05%
CORRADO ADVISORS, LLC 19,366$69,0000.04%
Cutter & CO Brokerage, Inc. 27,827$99,0000.02%
Ergoteles LLC 177,048$627,0000.02%
FULLER & THALER ASSET MANAGEMENT, INC. 941,760$3,334,0000.02%
View complete list of ENZO BIOCHEM INC shareholders